Putting together development plans for novel products which demonstrated positive results in medical research.
Getting local approvals and launching healthcare products around the world with our network of distributors and licensees.
Providing services around product licensing to the pharmaceutical and biotech industry and support to healthcare investors.
Small private companies may be able to progress the development of their compounds or technologies up to a point, but are normally unable to convert these into commercialised pharmaceutical products, on their own and on a worldwide basis, as they are not capable of setting up the infrastructure for marketing and distribution. The result is that the vast majority of biotech companies will be compelled to enter into corporate deals with pharma companies that have the means to commercialise on a large and global scale.
Our team of executives with years of experience in blue chip multinationals guides companies to success. Integrating transactional expertise and senior-level contacts in the industry and financial community, our mission is to help companies and investors crystalise value through deals: financing transactions and corporate collaborations. Our modus operandi is results-focused. We know a deal has to get done and results have to be delivered. We are here to help: help make a difference.